Dr. Eric Rovner, MD

NPI: 1841237013
Total Payments
$367,935
2024 Payments
$7,932
Companies
36
Transactions
299
Medicare Patients
8,241
Medicare Billing
$547,289

Payment Breakdown by Category

Consulting$278,491 (75.7%)
Travel$29,410 (8.0%)
Research$25,511 (6.9%)
Other$22,968 (6.2%)
Food & Beverage$11,556 (3.1%)

Payments by Nature

Nature of Payment Amount Transactions Share
Consulting Fee $278,491 61 75.7%
Travel and Lodging $29,410 32 8.0%
Unspecified $25,511 15 6.9%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $19,847 11 5.4%
Food and Beverage $11,556 178 3.1%
Honoraria $3,000 1 0.8%
Grant $121.00 1 0.0%

Payments by Type

General
$342,424
284 transactions
Research
$25,511
15 transactions

Top Paying Companies

Company Total Records Latest Year
Allergan, Inc. $200,505 44 $0 (2021)
Astellas Pharma Global Development $31,672 15 $0 (2020)
UROVANT SCIENCES INC $27,108 12 $0 (2022)
Sumitomo Pharma America, Inc. $19,369 10 $0 (2024)
Merck Sharp & Dohme Corporation $18,317 9 $0 (2018)
Astellas Pharma US Inc $17,126 13 $0 (2018)
Laborie Medical Technologies Corp. $7,125 3 $0 (2022)
Hologic, LLC $6,875 5 $0 (2020)
Axonics, Inc. $5,564 14 $0 (2024)
Medtronic, Inc. $5,008 20 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $7,932 29 Sumitomo Pharma America, Inc. ($4,059)
2023 $17,427 20 Sumitomo Pharma America, Inc. ($15,310)
2022 $29,921 66 UROVANT SCIENCES INC ($18,258)
2021 $25,786 21 UROVANT SCIENCES INC ($8,850)
2020 $89,242 27 Allergan, Inc. ($77,594)
2019 $111,300 41 Allergan Inc. ($103,757)
2018 $61,725 63 Merck Sharp & Dohme Corporation ($18,317)
2017 $24,602 32 Astellas Pharma Global Development ($15,381)

All Payment Transactions

299 individual payment records from CMS Open Payments — Page 1 of 12

Date Company Product Nature Form Amount Type
12/05/2024 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $16.59 General
Category: Sacral Nerve Stimulation
11/13/2024 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $27.43 General
Category: Sacral Nerve Stimulation
11/11/2024 Axonics, Inc. Axonics (Device) Food and Beverage In-kind items and services $149.89 General
Category: Urology
09/14/2024 Avation Medical, Inc. Vivally (Device) Food and Beverage Cash or cash equivalent $6.59 General
Category: Device
09/13/2024 Avation Medical, Inc. Vivally (Device) Food and Beverage Cash or cash equivalent $168.95 General
Category: Device
07/10/2024 PROCEPT BioRobotics Corporation AQUABEAM SYSTEM (Device) Food and Beverage Cash or cash equivalent $24.69 General
Category: UROLOGY
07/09/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $4.61 General
Category: UROLOGY
06/28/2024 PROCEPT BioRobotics Corporation AQUABEAM SYSTEM (Device) Food and Beverage Cash or cash equivalent $144.77 General
Category: UROLOGY
06/19/2024 Ambu Inc. Food and Beverage Cash or cash equivalent $94.36 General
06/13/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Consulting Fee Cash or cash equivalent $1,500.00 General
Category: UROLOGY
06/11/2024 PROCEPT BioRobotics Corporation AQUABEAM SYSTEM (Device) Food and Beverage Cash or cash equivalent $217.56 General
Category: UROLOGY
05/31/2024 Provepharm Inc. BLUDIGO (Drug) Consulting Fee Cash or cash equivalent $1,600.00 General
Category: MARKER DYE
05/22/2024 ABBVIE INC. Consulting Fee Cash or cash equivalent $387.50 General
05/17/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $21.91 General
Category: UROLOGY
05/04/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $125.00 General
Category: UROLOGY
05/04/2024 Medtronic, Inc. INTERSTIM (Device) Food and Beverage In-kind items and services $88.85 General
Category: Sacral Nerve Stimulation
05/03/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program In-kind items and services $122.00 General
Category: UROLOGY
05/03/2024 Sumitomo Pharma America, Inc. GEMTESA (Drug) Food and Beverage In-kind items and services $10.75 General
Category: UROLOGY
05/02/2024 BLUEWIND MEDICAL REVI (Device) Food and Beverage In-kind items and services $124.24 General
Category: BLADDER
04/30/2024 Axonics, Inc. Axonics (Device) Food and Beverage In-kind items and services $91.51 General
Category: Urology
04/08/2024 Boston Scientific Corporation Food and Beverage In-kind items and services $142.18 General
Category: General - Female SUI_URO
03/06/2024 Boston Scientific Corporation AdVance XP (Device) Food and Beverage In-kind items and services $26.31 General
Category: AdVance_URO
03/05/2024 Boston Scientific Corporation Food and Beverage In-kind items and services $93.60 General
Category: General - Erectile Dysfunction_URO
03/01/2024 180 Medical, Inc. GENTLECATH GLIDE (Device) Food and Beverage In-kind items and services $29.29 General
Category: CONTINENCE CARE
02/27/2024 Axonics, Inc. Bulkamid (Device) Food and Beverage In-kind items and services $138.44 General
Category: Urology

Research Studies & Clinical Trials

Study Name Company Amount Records
A Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder OAB Astellas Pharma Global Development $8,303 7
A Prospective, Non-Interventional, Registry Study of Patients Initiating a Course of Drug Therapy for Overactive Bladder (OAB) Astellas Pharma Global Development $4,106 1
Prospective, Non-interventional, Registry Study of Patients Initiating a Course of DrugTherapy for Overactive Bladder OAB Astellas Pharma Global Development $3,195 1
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder OAB Astellas Pharma Global Development $3,195 1
TITAN 2 Medtronic, Inc. $3,144 2
Penguin Cytyc Surgical Products, LLC $1,971 1
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder OAB PERSPECTIVE Astellas Pharma Global Development $798.83 1
A Prospective, Observational, Multicenter Study of Patients Following Initiation of a New Course of Treatment for Overactive Bladder (OAB) Astellas Pharma Global Development $798.67 1

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 19 1,768 1,972 $948,814 $119,541
2022 17 2,024 2,282 $1.0M $142,001
2021 23 2,249 2,599 $1.2M $158,012
2020 21 2,200 2,500 $974,113 $127,734
Total Patients
8,241
Total Services
9,353
Medicare Billing
$547,289
Procedure Codes
126

All Medicare Procedures & Services

126 procedure records from CMS Medicare Utilization — Page 2 of 6

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
51600 Injection procedure for imaging of bladder during voiding Facility 2023 28 28 $15,148 $410.75 2.7%
51784 Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings Facility 2023 26 26 $10,062 $348.25 3.5%
74455 Review by radiologist of urinary bladder and urethra images with contrast and after passing urine Facility 2023 27 27 $5,373 $308.36 5.7%
51741 Electronic assessment of bladder emptying Facility 2023 64 72 $20,232 $244.98 1.2%
51701 Insertion of temporary bladder tube Facility 2023 11 11 $5,896 $209.33 3.6%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 203 264 $65,136 $23,594 36.2%
52000 Diagnostic exam of bladder and urethra using an endoscope Office 2022 132 142 $98,878 $22,406 22.7%
51728 Complex measurement of pressure of urine flow in bladder with voiding pressure studies Office 2022 60 61 $91,927 $15,777 17.2%
99214 Established patient office or other outpatient visit, 30-39 minutes Facility 2022 128 149 $36,599 $9,936 27.1%
51797 Insertion of device into abdomen with pressure and urine flow rate study Office 2022 67 68 $43,959 $9,846 22.4%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2022 86 86 $29,548 $9,636 32.6%
52287 Exam with injections of chemical for destruction of bladder using an endoscope Facility 2022 52 77 $109,331 $8,780 8.0%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 80 91 $15,665 $5,778 36.9%
99204 New patient office or other outpatient visit, 45-59 minutes Facility 2022 59 59 $20,533 $5,575 27.2%
74455 Review by radiologist of urinary bladder and urethra images with contrast and after passing urine Office 2022 69 70 $66,290 $5,481 8.3%
51600 Injection procedure for imaging of bladder during voiding Office 2022 67 68 $34,583 $5,429 15.7%
52000 Diagnostic exam of bladder and urethra using an endoscope Facility 2022 80 81 $56,181 $4,143 7.4%
99213 Established patient office or other outpatient visit, 20-29 minutes Facility 2022 77 83 $14,265 $3,679 25.8%
51728 Complex measurement of pressure of urine flow in bladder with voiding pressure studies Facility 2022 28 28 $18,928 $1,967 10.4%
51784 Non-needle measurement and recording of electrical activity of muscles at bladder and bowel openings Office 2022 67 68 $62,356 $1,625 2.6%
51798 Ultrasound measurement of bladder capacity after voiding Office 2022 159 196 $42,924 $1,405 3.3%
52204 Biopsy of bladder using an endoscope Facility 2022 15 15 $17,711 $1,275 7.2%
51797 Insertion of device into abdomen with pressure and urine flow rate study Facility 2022 35 35 $9,170 $1,004 11.0%
51741 Electronic assessment of bladder emptying Office 2022 135 153 $80,019 $953.01 1.2%
81002 Urinalysis, manual test Office 2022 196 243 $5,589 $832.97 14.9%

About Dr. Eric Rovner, MD

Dr. Eric Rovner, MD is a Urology healthcare provider based in Charleston, South Carolina. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1841237013.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Eric Rovner, MD has received a total of $367,935 in payments from pharmaceutical and medical device companies, with $7,932 received in 2024. These payments were reported across 299 transactions from 36 companies. The most common payment nature is "Consulting Fee" ($278,491).

As a Medicare-enrolled provider, Rovner has provided services to 8,241 Medicare beneficiaries, totaling 9,353 services with total Medicare billing of $547,289. Data is available for 4 years (2020–2023), covering 126 distinct procedure/service records.

Practice Information

  • Specialty Urology
  • Other Specialties Urogynecology and Reconstructive Pelvic Surgery
  • Location Charleston, SC
  • Active Since 05/31/2006
  • Last Updated 10/20/2020
  • Taxonomy Code 208800000X
  • Entity Type Individual
  • NPI Number 1841237013

Products in Payments

  • BOTOX (Drug) $77,117
  • BOTOX (Biological) $71,639
  • GEMTESA (Drug) $44,202
  • BOTOX COSMETIC (Biological) $24,039
  • MIRABEGRON (Drug) $20,606
  • Myrbetriq (Drug) $15,381
  • MYRBETRIQ (Drug) $12,810
  • MK-7264 (Drug) $7,150
  • Axonics r-SNM System (Device) $5,402
  • Noctiva (Drug) $4,516
  • BOTOX THERAPEUTIC - HH (Biological) $4,176
  • NOCDURNA (Drug) $3,000
  • INTERSTIM (Device) $2,568
  • RENOVA $2,378
  • BLUDIGO (Drug) $1,600
  • eCoin Device Kit (Device) $894.70
  • ACT (Device) $736.00
  • Axonics (Device) $724.76
  • Bulkamid (Device) $584.17
  • AQUABEAM ROBOTIC SYSTEM (Device) $575.03

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Urology Doctors in Charleston